| 1 |
Yagel S, Silverman NH, Gembruch U. Fetal Cardiology: Embryology, genetics, physiology, echocardiographic evaluation, diagnosis and perinatal management of cardiac diseases.2nd ed[M]. New York: Informa Healthcare USA, 2008, 131-149.
|
| 2 |
Yang SY, Chen SB. Pediatric cardiology.4th ed[M]. Bejing: People's Medical Publishing House, 2012, 28-33.
|
| 3 |
Makrydimas G. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers[J]. Am J Obstet Gynecol, 2005, 192(1)：89-95.
|
| 4 |
Tworetzky W, Wilkins-Haug L, Jennings RW, et al. Balloon dilation of severe aortic stenosis in the fetus: Potential for prevention of hypoplastic left heart syndrome: Candidate selection, technique, and results of successful intervention[J]. Circulation, 2004, 12: 2125-2131.
|
| 5 |
Mizrahi-Arnaud A, Tworetzky W, Bulich LA, et al. Pathophysiology, management, and outcomes of fetal hemodynamic instability during prenatal cardiac intervention[J]. Pediatr Res, 2007, 62：325-330.
|
| 6 |
Marshall AC, Levine J, Morash D, et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome[J]. Prenat Diagn, 2008, 28：1023-1028.
|
| 7 |
Tworetzky W, McElhinney DB, Marx GR, et al. In utero valvuloplasty for pulmonary valve atresia with hypoplastic right ventricle: Techniques and outcomes[J]. Pediatrics, 2009, 24：1102-1109.
|
| 8 |
McElhinney DB, Marshall AC, Wilkins-Haug LE, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome[J]. Circulation, 2009, 120：1482-1490.
|
| 9 |
Makrydimas G. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol. 2005; 192(1)：89-95.
|
| 10 |
Allan LD. Cardiac anatomy screening: What is the best time for screening in pregnancy[J]? Curr Opin Obst Gynecol，2003, 15(2)：143-146.
|
| 11 |
Carvalho JS. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies[J]. Heart, 2004, 90：921-926.
|
| 12 |
Kleinman CS. Cardiac arrhythmias in the human fetus[J]. Pediatr Cardiol, 2004, 25(3): 234-251.
|
| 13 |
McElhinney DB, Tworetzky W, Lock JE. Current status of fetal cardiac intervention[J]．Circulation, 2010, 121：1256-1263.
|
| 14 |
van den Heuvel F, Bink-Boelkens MT, du Marchie-Sarvaas GJ, et al. Drug management of fetal tachyarrhythmias: Are we ready for a systematic and evidence-based approach[J]? Pacing Clin Electrophysiol, 2008, 31(suppl 1)：S54-S57.
|
| 15 |
Funda O, Resmiye B, Ayfle G, Ahunbay G. Fetal arrhythmias diagnosis, treatment and prognosis[J]. Anadolu Kardiyol Derg.2003, 3(3)：211-215.
|
| 16 |
Cornelia H, Manfred H, Sturlia H, et al. A cardiovascular profile score in surveillance of fetal hydrops[J]. J Maternal-Fetal Neonatal Med, 2006, 19(7): 407-413.
|
| 17 |
Huhta JC.Fetal congestive heart failure[J]．Semin Fetal Neonatal Med，2005, 10(6)：542-552.
|
| 18 |
Falkensammer F, James P, Huhta JC. Fetal congestive heart failure: Correlation of Tei-index and cardiovascular-score[J]. J Perinat Med, 2001, 29：390-398.
|
| 19 |
Zhou KY, Hua YM, Zhu Q, et al. Transplacental digoxin therapy for fetal tachyarrhythmia with multiple evaluation systems. J Matern Fetal Neonatal Med, 2011, 24(11)：1378-1383.
|